Free Trial

Ameriprise Financial Inc. Increases Stock Position in Xylem Inc. $XYL

Xylem logo with Business Services background

Key Points

  • Ameriprise Financial Inc. increased its stake in Xylem Inc. by 9.7%, owning 1,910,172 shares worth $228.19 million after acquiring 168,766 shares in the first quarter.
  • Analysts have a positive outlook for Xylem, with six rating it a "Buy" and a consensus price target of $151.57, highlighting several upward adjustments made to target prices by firms including UBS and Citigroup.
  • Xylem recently reported a quarterly earnings per share of $1.26, exceeding expectations, and announced a quarterly dividend of $0.40 per share with a current dividend yield of 1.1%.
  • Want stock alerts on Xylem? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Ameriprise Financial Inc. increased its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 9.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,910,172 shares of the industrial products company's stock after buying an additional 168,766 shares during the quarter. Ameriprise Financial Inc. owned about 0.78% of Xylem worth $228,189,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Valley National Advisers Inc. boosted its holdings in Xylem by 84.9% in the 1st quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock valued at $26,000 after purchasing an additional 101 shares in the last quarter. Perkins Coie Trust Co purchased a new stake in Xylem in the 1st quarter valued at approximately $27,000. Center for Financial Planning Inc. boosted its holdings in Xylem by 52.0% in the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 91 shares in the last quarter. Heck Capital Advisors LLC purchased a new stake in Xylem in the 4th quarter valued at approximately $36,000. Finally, Headlands Technologies LLC boosted its stake in shares of Xylem by 90.6% during the 1st quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company's stock worth $36,000 after acquiring an additional 145 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on XYL. JPMorgan Chase & Co. began coverage on Xylem in a research note on Friday, May 30th. They set an "overweight" rating and a $148.00 price target on the stock. Citigroup reissued a "buy" rating and set a $152.00 price target (up previously from $137.00) on shares of Xylem in a research note on Monday, July 14th. UBS Group boosted their price target on Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a research note on Tuesday, August 5th. Wall Street Zen raised Xylem from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Finally, Robert W. Baird decreased their price target on Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 30th. Six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $151.57.

Get Our Latest Stock Report on Xylem

Xylem Trading Down 0.7%

XYL traded down $0.9850 during trading on Monday, hitting $142.7550. The company's stock had a trading volume of 897,193 shares, compared to its average volume of 1,243,124. The firm's 50 day moving average price is $134.57 and its 200-day moving average price is $126.47. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. The stock has a market cap of $34.75 billion, a PE ratio of 37.08, a PEG ratio of 2.49 and a beta of 1.11. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $145.33.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.11. The company had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.Xylem's revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, August 28th. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. Xylem's payout ratio is currently 41.56%.

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Read More

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines